Melanoma inhibitory activity (MIA), a serological marker of malignant melanoma

Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer

Volumn 158, Issue , 2001, Pages 158-168

  Bosserhoff, A K ^a   Dreau, D ^d   Hein, R ^c   Landthaler, M ^b   Holder, W D ^d   Buettner, R ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d Department of General Surgery Research ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; ANTINEOPLASTIC AGENT; CANCER VACCINE; INTERLEUKIN 2; MIA PROTEIN, HUMAN; MONOCLONAL ANTIBODY; POLYVALENT MELANOMA CELL VACCINE; SCLEROPROTEIN; TUMOR MARKER; TUMOR PROTEIN;

ANIMAL; ARTICLE; BLOOD; CANCER STAGING; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HAMSTER; HUMAN; MALE; MELANOMA; MIDDLE AGED; PREDICTION AND FORECASTING; PROSPECTIVE STUDY; SKIN TUMOR; TUMOR RECURRENCE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; CANCER VACCINES; CRICETINAE; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX PROTEINS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERFERON ALFA-2B; INTERLEUKIN-2; MALE; MELANOMA; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0035228615     PISSN: 00800015     EISSN: None     Source Type: Journal    
DOI: 10.1007/978-3-642-59537-0_16     Document Type: Article

References (0)